What is a PET/CT scan with PSMA Tracer?
A PET/CT scan that uses PSMA tracer can help identify prostate cancer. The PSMA Tracer agent is injected by IV (intravenously), and attaches to prostate cancer cells, both in the prostate, as well as in metastases. Once it has attached to the cells, it sends out signals that are picked up by the PET/CT scanner, allowing it to form a picture of the location of any prostate cancer that might be present in the body. This provides more accurate and earlier detection of prostate cancer, helping doctors and patients make better-informed treatment decisions.
As with all cancers, an important part of the treatment process is detecting the cancer as early as possible. PET Imaging now offers a PSMA PET/CT scan. PSMA is used for men with prostate cancer:
- With Suspected Metastases
- With Suspected Recurrences
- For Staging With Suspected Metastases
- For Restaging With Elevated PSA
PSMA scans are able to detect cancer that is located in:
- Bones
- Soft Tissue
- The Prostate or Prostate Bed
- Small Tumors
- Patients With Lower PSA Levels
Some added benefits to using PSMA tracers with PET/CT scans include being minimally invasive and often replacing the need for surgical biopsies, it’s ability to locate very small tumors more accurately compared to other tests, and it’s ability focus on prostate cancer by targeting PSMA protein, which is found on the surface of more than 90% of prostate cancer cells. There is a added risk of the small amount of radiation with the scan. Excessive radiation can increase the risk for cancer, however the small amount of radiation received from this scan alone has been determined to be unlikely to cause cancer. During your consultation, our medical team will recommend this test only if it is determined to be of benefit to you in finding prostate cancer. If you are interested in getting a PSMA scan, please fill out the form, and one of our team members will contact you to set up an appointment.